Kiwi company Douglas Pharmaceuticals has won approval to sell its locally developed acne medication in the United States.
The Auckland company has been trying for a decade to break into the US acne medication market, which is worth about US$400 million (NZ$494m).
its new medication, isotretinoin, now has Food and Drug Administration approval.
The company is new Zealand’s largest manufacturer of pharmaceuticals, specialising in immuno-suppression, central nervous system, oncology and dermatology products.
It already sells to 35 countries, with an export turnover of $85m.
Director Jeff Douglas said in a statement that it was a breakthrough and would …